Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
David J. Horin is a seasoned financial executive and independent director who currently serves on the board of Jones Ventures INTL Acquisition1 Corp (NASDAQ: JONEU), a special purpose acquisition company headquartered at 325 Hudson Street, 6th Floor, New York, NY. He was appointed as an independent director upon the trading of the company's securities on Nasdaq and qualifies as the audit committee financial expert. In connection with his board appointment on July 13, 2026, Horin was assigned 30,000 Class B ordinary shares by the sponsor at a stated price of $0.003 per share. These shares are automatically convertible into an equal number of Class A ordinary shares upon the issuer's initial business combination on a one-for-one basis, subject to anti-dilution rights and forfeiture provisions tied to his continued board service. He filed his initial Form 3 on July 16, 2026, reporting his position solely as a director with no officer or ten-percent-owner designation.
Horin brings over 35 years of financial consulting and executive management experience across a broad range of industries including life sciences, technology, financial services, media, and entertainment. He is currently a Partner in the Advisory practice at WilliamsMarston LLC, a financial consulting firm, having joined after founding and serving as Managing Partner of Chord Advisors, LLC, a boutique accounting advisory firm that served more than 400 pre-IPO, public, and private equity-backed growth companies on technical accounting, SEC reporting, and capital markets transactions. During his tenure at Chord Advisors, Horin also served as interim Chief Financial Officer for a biotechnology company, guiding it through a period of significant growth and transformation until its eventual sale to a large public pharmaceutical company. Through Chord, he also provided interim CFO and advisory accounting services to Mustang Bio, Inc. and Checkpoint Therapeutics Inc., and served as CFO of Protagenic Therapeutics Inc. (PTIX). From May 2023 to June 2025, Horin served as both Chief Financial Officer and a member of the Board of Directors of Eagle Football Holdings Ltd.
Earlier in his career, Horin served as Chief Financial Officer of Rodman & Renshaw Capital Group, Inc., a full-service investment bank, from 2008 to June 2012, during which time he was nominated by Sandler O'Neill Research in 2010 and 2011 as "Institutional Investor Magazine Top CFO – Brokers & Asset Managers." Prior to Rodman & Renshaw, from 2003 to 2008, he was Managing Director of Accounting Policy and Financial Reporting (and Chief Accounting Officer) at Jefferies Group, Inc. (now Jefferies Financial Group Inc.), where he led global technical accounting, SEC reporting, and Sarbanes-Oxley efforts. From 2000 to 2003, Horin was a Senior Manager in KPMG LLP's Department of Professional Practice (National Office) and Transaction Services practice in New York, where he was one of fifteen professionals selected for a prestigious worldwide rotational assignment advising firm members and clients on technical accounting, auditing, and SEC filing matters related to mergers and acquisitions, consolidations, financial reporting, capital structure formation, and stock-based compensation. He was also a contributing author to KPMG's "Defining the Digital Future: Business and Accounting Issues" published in November 2000. In September 2014, he was appointed Chief Financial Officer of WPCS International Incorporated (NASDAQ: WPCS), a communications infrastructure contracting and digital currency trading platform company.
Horin holds a Bachelor of Business Administration degree with a concentration in Accounting from Baruch College, City University of New York, where he graduated with honors. He is a Certified Public Accountant licensed in the State of California. His insider ownership footprint spans at least three publicly traded companies — Mustang Bio Inc. (MBIO), Checkpoint Therapeutics Inc. (CKPT), and Protagenic Ther
This record is keyed to SEC CIK 0001429468 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row.